As one of leading biotechnology company in Republic of Korea, Korea Bone Bank Co., Ltd. aims to become a top musculoskeletal biotechnology company through continuous Research and Development in the field of orthobiologics, medical device, bio-similar, and cell therapy.

Korea Bone Bank has poured huge investment in RD in pursuit of improving arthoplasty, spinal implants, and bone human recombinant protein (BMP 2). Also KBB has been conducting joint research with several medical and engineering schools to share innovative ideas and acquire new perspectives.

KBB is committed to the improvement of human health and the quality of life. We will continue to strive toward our goal of putting smiles on our patients faces as they recover their health and look forward better life.

Visit www.kbbcom.co.kr to see the innovative products of Korea Bone Bank.